Compare Novavax Inc (NVAX) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Tempus AI — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Tempus AI trades at $49.08 (market cap $8.69B). The key difference: Tempus AI is far larger — about 6.7× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| NVAX | TEM | |
|---|---|---|
Market Cap | $1.30B | $8.69B |
Sector | Health | Broad Market / Factor |
52-Week High | $11.19 | $103.25 |
52-Week Low | $6.22 | $42.37 |
Enterprise Value | $800.50M | $9.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
